Skip to main content
. 2021 Jan 21;26(3):553. doi: 10.3390/molecules26030553

Figure 1.

Figure 1

FDA-approved angiogenesis inhibitors for treatment of cancer [18,19]. VEGFR, vascular endothelial growth factor receptor.